antibiotics (p=.88), necrosis requiring surgery (p=.95), seroma (p=.82) and device exchange (p=.53) were equivalent. There were no significant differences in the mean number of complication-related surgeries before (p=.95) or after (p=.89) implant, revision surgeries (p=.27), or total surgeries (p=.45). There were no significant differences in the percentages of patients undergoing at least one complication-related surgery before implant (p=.64), at least one complication-related surgery after implant (p=.93), or at least one revision surgery (p=.23).
CONCLUSIONS:
When comparing patients that completed implant based reconstruction, combining riskreducing gynecologic procedures with mastectomy and reconstruction into one OR visit does not appear to negatively impact reconstructive outcomes. Subgroup analysis revealed no significant differences in complication rates. Patients who would benefit from combined risk-reducing gynecologic procedures can be encouraged to do so. 
PURPOSE:
Although reduction mammaplasty is associated with improved health-related quality of life (HRQOL), surgical treatment for younger patients remains controversial. This study measures complications following reduction mammaplasty in adolescents and young women, and the impact of surgical complications on HRQOL outcomes.
METHODS:
Clinical evaluations were performed and validated surveys were administered to skeletally mature patients undergoing reduction mammaplasty: Short-Form 36v2 (SF-36), Rosenberg Self-Esteem Scale (RSES), Breast-Related Symptoms Questionnaire (BRSQ), and Eating-Attitudes
